Rapid Diagnostic Test for Visceral Leishmaniasis (Kala-azar): Introduction, Principle, Procedure, Result-Interpretation, Clinical Significance and Keynnotes
An InBiOS Detect rapid diagnostic test for Visceral Leishmaniasis (Kala-azar) that appears to show two visible lines, which is consistent with a positive antibody result
Introduction
Table of Contents
The Rapid Diagnostic Test (RDT) for Visceral Leishmaniasis (VL), often known as the rK39 test or Kalazar Detect™, is a specific, non-invasive immunochromatographic assay used to detect antibodies against Leishmania parasites in human serum or blood.
Visceral Leishmaniasis (Kala-azar) is a severe, potentially fatal vector-borne disease caused by Leishmania parasites. RDTs are critical innovations in control programs because they provide fast results (within 10–20 minutes) and are field-friendly, requiring no specialized laboratory equipment or refrigeration.
Principle
The test operates on the principle of lateral flow immunochromatography.
Antigen: It uses the recombinant rK39 antigen, which is a 39-amino-acid repeat segment from the kinesin-related protein found in Leishmania species like L. donovani and L. infantum.
Mechanism: The test membrane is pre-coated with rK39 at the test line and a control antibody (e.g., chicken anti-protein A) at the control line. When a sample containing anti-rK39 antibodies is added, it reacts with a dye conjugate (like colloidal gold). This complex migrates up the strip and is captured by the immobilized rK39, forming a visible colored line.
Procedure (e.g., InBios Kalazar Detect™)
Sample Collection: Collect approximately 20 μL of serum or one drop of finger-prick blood.
Application: Add the sample to the designated sample pad area at the base of the dipstick.
Buffer Addition: Place the dipstick vertically into a test tube or well containing 2–3 drops (approx. 150 μL) of chase buffer.
Incubation: Wait for exactly 10 minutes before reading the results.
Result Interpretation of Rapid Diagnostic Test for Visceral Leishmaniasis
Results must be interpreted within the specified timeframe to avoid misleading readings.
Fig. An InBiOS Detect rapid diagnostic test for Visceral Leishmaniasis (Kala-azar) that appears to show two visible lines, which is consistent with a positive antibody result
Result Type
Appearance
Meaning
Positive
Two red lines appear: one at the control (C) area and one at the test (T) area.
Antibodies to VL detected; consistent with infection.
Negative
Only one red line appears at the control (C) area.
No antibodies detected.
Invalid
No line appears at the control (C) area, even if a line appears at the test area.
Test failed; repeat with a new strip.
Clinical Significance of Rapid Diagnostic Test for Visceral Leishmaniasis
High Performance: In the Indian subcontinent, the rK39 test has high sensitivity (97%) and specificity, making it a reliable indicator for diagnosis.
Bedside Diagnosis: Its ease of use allows for diagnosis in peripheral health centers, ensuring patients receive prompt treatment without traveling to distant hospitals.
Limitations:
Asymptomatic Positives: Some healthy individuals in endemic areas may test positive due to past exposure or subclinical infection.
Regional Variation: Sensitivity is lower in East Africa (~85%) compared to India.
HIV Co-infection: The test may have lower accuracy in patients co-infected with HIV.
Keynotes
Not a Test of Cure: Because antibodies persist for months or even years after recovery, the RDT cannot be used to monitor treatment success or diagnose a relapse.
Clinical Context: The test should only be applied to patients who already meet the clinical case definition for VL (e.g., prolonged fever >2 weeks and splenomegaly).
Storage: Most kits are stable at room temperature (20°C–30°C), which is essential for use in tropical endemic regions.